AQR Arbitrage’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

AQR Arbitrage’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-247,948	Closed	-$942K	–	606
2020 Q1	$942K	Sell	247,948 -807,916	-77%	-$3.48M	0.03%	280
2019 Q4	$5.37M	Buy	+1,055,864	New	+$5.59M	0.09%	183

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

AQR Arbitrage's PGNX Position: Q2 2020 in Review

AQR Arbitrage sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 247,948 shares — an estimated $942K sold.

AQR Arbitrage first reported a position in PGNX in Q4 2019 and held it in 2 quarters. The position peaked at $5.37M in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

AQR Arbitrage reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
AQR Arbitrage sold 247,948 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $942K.
AQR Arbitrage first reported a position in Progenics Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
AQR Arbitrage's Progenics Pharmaceuticals Inc position peaked at $5.37M in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on AQR Arbitrage's 13F filing for Q2 2020, filed 17 Aug 2020.